These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38232458)
1. Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy. Huang C; Guo Y; Li T; Sun G; Yang J; Wang Y; Xiang Y; Wang L; Jin M; Li J; Zhou Y; Han B; Huang R; Qiu J; Tan Y; Hu J; Wei Y; Wu B; Mao Y; Lei L; Song X; Li S; Wang Y; Zhang T Redox Biol; 2024 Apr; 70():103024. PubMed ID: 38232458 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803 [TBL] [Abstract][Full Text] [Related]
4. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis. Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis. Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222 [TBL] [Abstract][Full Text] [Related]
6. MG53 inhibits ferroptosis by targeting the p53/SLC7A11/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity. Jiang W; Yu L; Mu N; Zhang Z; Ma H Free Radic Biol Med; 2024 Oct; 223():224-236. PubMed ID: 39111582 [TBL] [Abstract][Full Text] [Related]
7. Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway. Shu G; Chen K; Li J; Liu B; Chen X; Wang J; Hu X; Lu W; Huang H; Zhang S Phytomedicine; 2024 Nov; 134():155989. PubMed ID: 39217656 [TBL] [Abstract][Full Text] [Related]
8. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice. Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338 [TBL] [Abstract][Full Text] [Related]
9. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity. Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422 [TBL] [Abstract][Full Text] [Related]
10. Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via Nrf2/GPX4 pathway. Wang Y; Han J; Zhan S; Guo C; Yin S; Zhan L; Zhou Q; Liu R; Yan H; Wang X; Yan D Int J Biol Macromol; 2024 Sep; 276(Pt 1):133792. PubMed ID: 38992539 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway. Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782 [TBL] [Abstract][Full Text] [Related]
12. Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling. Yu Y; Wu T; Lu Y; Zhao W; Zhang J; Chen Q; Ge G; Hua Y; Chen K; Ullah I; Zhang F Free Radic Biol Med; 2022 Nov; 193(Pt 1):108-121. PubMed ID: 36241072 [TBL] [Abstract][Full Text] [Related]
13. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Wang Y; Yan S; Liu X; Deng F; Wang P; Yang L; Hu L; Huang K; He J Cell Death Differ; 2022 Oct; 29(10):1982-1995. PubMed ID: 35383293 [TBL] [Abstract][Full Text] [Related]
14. Ferroptosis as a target for protection against cardiomyopathy. Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261 [TBL] [Abstract][Full Text] [Related]
15. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM Cells; 2020 Sep; 9(10):. PubMed ID: 32992522 [TBL] [Abstract][Full Text] [Related]
16. Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway. Xue S; Chen H; Zhang J; Tian R; Xie C; Sun Q; Wang H; Shi T; Guo D; Wang Y; Wang Q J Ethnopharmacol; 2024 Dec; 335():118604. PubMed ID: 39047881 [TBL] [Abstract][Full Text] [Related]
17. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway. Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624 [TBL] [Abstract][Full Text] [Related]
18. Lipid discovered in American ginseng alleviates doxorubicin-induced cardiotoxicity by inhibiting cardiomyocyte ferroptosis. Hu K; Wang H; Wang H; Li T; Liu L; Zhang H; Li Z; Wang S; Han L Fitoterapia; 2024 Sep; 177():106097. PubMed ID: 38945490 [TBL] [Abstract][Full Text] [Related]
19. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379 [TBL] [Abstract][Full Text] [Related]
20. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol. Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]